Funding for this research was provided by:
the National Natural Science Foundation of China ((No. 81872125))
the Promotion Project of Standardized Diagnosis and Treatment Technology (No. LNCCC‐ a01‐2015)
Basic and Clinical Research on the Accurate Treatment of OC Based on Dig Data from China Medical University Subject Ascension Project in 2017 (No. 2017CXTD05)
Shengjing Free Researcher Project (No. 201704)
The mechanism of miRNA-130 regulating PARP-1 resistance in OC (No.201601128)
Article History
Received: 18 January 2020
Accepted: 31 July 2020
First Online: 5 August 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.